Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19

BACKGROUND: Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19) under the presumption that such plasma contains potentially therapeutic antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that can be passively transferred to the plasma recipie...

Descripción completa

Detalles Bibliográficos
Autores principales: Joyner, Michael J., Carter, Rickey E., Senefeld, Jonathon W., Klassen, Stephen A., Mills, John R., Johnson, Patrick W., Theel, Elitza S., Wiggins, Chad C., Bruno, Katelyn A., Klompas, Allan M., Lesser, Elizabeth R., Kunze, Katie L., Sexton, Matthew A., Diaz Soto, Juan C., Baker, Sarah E., Shepherd, John R.A., van Helmond, Noud, Verdun, Nicole C., Marks, Peter, van Buskirk, Camille M., Winters, Jeffrey L., Stubbs, James R., Rea, Robert F., Hodge, David O., Herasevich, Vitaly, Whelan, Emily R., Clayburn, Andrew J., Larson, Kathryn F., Ripoll, Juan G., Andersen, Kylie J., Buras, Matthew R., Vogt, Matthew N.P., Dennis, Joshua J., Regimbal, Riley J., Bauer, Philippe R., Blair, Janis E., Paneth, Nigel S., Fairweather, DeLisa, Wright, R. Scott, Casadevall, Arturo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821984/
https://www.ncbi.nlm.nih.gov/pubmed/33523609
http://dx.doi.org/10.1056/NEJMoa2031893

Ejemplares similares

Ejemplares similares